Pharmacopeia (USP) Dietary Supplements Information Expert Committee (DSI-EC) voted to require cautionary statements on the labels for green tea extracts and black cohosh dietary supplements.
GLP-1 drugs are not approved MS treatments, but early research suggests that they may affect inflammation and nerve health in ways that could be relevant to MS
Warning labels on Mounjaro, Ozempic, and a whole host of other similar type 2 diabetes drugs list gastrointestinal problems, such as the following, as potential side effects associated with them: Abdominal discomfort or pain Nausea Bloating Vomiting Constipation Discolored stools Indigestion Diarrhea However, in entering Ozempic, Mounjaro, and other similar medications into the FDA Adverse Events Reporting System (FAERS) Public Dashboard, thousands of reports of much more serious adverse side effects, including the following, come up: Pancreatitis Gallbladder issues Kidney failure Thyroid tumors Cancer Gastroparesis Gastroparesis, also known as stomach paralysis, is what has led to many patients filing lawsuits against the drugs manufacturers most recently
For instance, the addition of monovalent cations, such as NH 4 + to a final 0.1 M peptide (poly (Glu-Leu)) solution, induces a transition to a water soluable beta-structure
44: Clinicians should advise patients with dumping syndrome to reduce the amount of food consumed at each meal
